123 related articles for article (PubMed ID: 19175177)
21. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
Al-Qallaf B; Das DB
Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
[TBL] [Abstract][Full Text] [Related]
22. Controlled transdermal delivery of model drug compounds by MEMS microneedle array.
Xie Y; Xu B; Gao Y
Nanomedicine; 2005 Jun; 1(2):184-90. PubMed ID: 17292077
[TBL] [Abstract][Full Text] [Related]
23. Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII.
Ramanathan MP; Kutzler MA; Kuo YC; Yan J; Liu H; Shah V; Bawa A; Selling B; Sardesai NY; Kim JJ; Weiner DB
Vaccine; 2009 Jul; 27(32):4370-80. PubMed ID: 19497647
[TBL] [Abstract][Full Text] [Related]
24. [Effect of Myostatin gene vaccine on immunized mice].
Wu SZ; Chen SL; He LQ; Zhang K; Tang L; Qin X; Zhang YQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):319-21, 324. PubMed ID: 19351500
[TBL] [Abstract][Full Text] [Related]
25. Improved cellular immune response elicited by a ubiquitin-fused ESAT-6 DNA vaccine against Mycobacterium tuberculosis.
Wang QM; Kang L; Wang XH
Microbiol Immunol; 2009 Jul; 53(7):384-90. PubMed ID: 19563397
[TBL] [Abstract][Full Text] [Related]
26. Immunogencity of HSA-L7/L12 (Brucella abortus ribosomal protein) in an animal model.
Pakzad I; Rezaee A; Rasaee MJ; Tabbaraee B; Delpisheh A
Iran J Immunol; 2009 Mar; 6(1):12-21. PubMed ID: 19293473
[TBL] [Abstract][Full Text] [Related]
27. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice.
Wang H; He S; Yao Y; Cong H; Zhao H; Li T; Zhu XQ
Exp Parasitol; 2009 Jul; 122(3):226-32. PubMed ID: 19366622
[TBL] [Abstract][Full Text] [Related]
28. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system.
Widera G; Johnson J; Kim L; Libiran L; Nyam K; Daddona PE; Cormier M
Vaccine; 2006 Mar; 24(10):1653-64. PubMed ID: 16246466
[TBL] [Abstract][Full Text] [Related]
29. [Experimental study on the chitosan-DNA vaccines against campylobacter jejuni invasion].
Zheng H; Cai FC; Zhong M; Deng B; Li X; Zhang XP
Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Sep; 41(5):375-9. PubMed ID: 18206008
[TBL] [Abstract][Full Text] [Related]
30. Polyplex-releasing microneedles for enhanced cutaneous delivery of DNA vaccine.
Kim NW; Lee MS; Kim KR; Lee JE; Lee K; Park JS; Matsumoto Y; Jo DG; Lee H; Lee DS; Jeong JH
J Control Release; 2014 Apr; 179():11-7. PubMed ID: 24462900
[TBL] [Abstract][Full Text] [Related]
31. The effect of conjugation to gold nanoparticles on the ability of low molecular weight chitosan to transfer DNA vaccine.
Zhou X; Zhang X; Yu X; Zha X; Fu Q; Liu B; Wang X; Chen Y; Chen Y; Shan Y; Jin Y; Wu Y; Liu J; Kong W; Shen J
Biomaterials; 2008 Jan; 29(1):111-7. PubMed ID: 17905427
[TBL] [Abstract][Full Text] [Related]
32. Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein.
Oh JH; Park HH; Do KY; Han M; Hyun DH; Kim CG; Kim CH; Lee SS; Hwang SJ; Shin SC; Cho CW
Eur J Pharm Biopharm; 2008 Aug; 69(3):1040-5. PubMed ID: 18411045
[TBL] [Abstract][Full Text] [Related]
33. Mass producible and biocompatible microneedle patch and functional verification of its usefulness for transdermal drug delivery.
Jin CY; Han MH; Lee SS; Choi YH
Biomed Microdevices; 2009 Dec; 11(6):1195-203. PubMed ID: 19609679
[TBL] [Abstract][Full Text] [Related]
34. Molecular adjuvants for malaria DNA vaccines based on the modulation of host-cell apoptosis.
Bergmann-Leitner ES; Leitner WW; Duncan EH; Savranskaya T; Angov E
Vaccine; 2009 Sep; 27(41):5700-8. PubMed ID: 19576940
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo studies evaluating recombinant plasmid pCXN2-mIzumo as a potential immunocontraceptive antigen.
An G; Huang TH; Wang DG; Xie QD; Ma L; Chen DY
Am J Reprod Immunol; 2009 Mar; 61(3):227-35. PubMed ID: 19239425
[TBL] [Abstract][Full Text] [Related]
36. Immune responses generated by intramuscular DNA immunization of Brugia malayi transglutaminase (BmTGA) in mice.
Vanam U; Prabhu PR; Pandey V; Dakshinamurthy G; Reddy MV; Perumal K
Parasitology; 2009 Jul; 136(8):887-94. PubMed ID: 19523247
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model.
Chiang CH; Huang WF; Huang LP; Lin SF; Yang WJ
Vaccine; 2009 Jul; 27(34):4565-70. PubMed ID: 19520199
[TBL] [Abstract][Full Text] [Related]
38. Effect of immunological adjuvants: GM-CSF (granulocyte-monocyte colony stimulating factor) and IL-23 (interleukin-23) on immune responses generated against hepatitis C virus core DNA vaccine.
Hartoonian C; Ebtekar M; Soleimanjahi H; Karami A; Mahdavi M; Rastgoo N; Azadmanesh K
Cytokine; 2009 Apr; 46(1):43-50. PubMed ID: 19278866
[TBL] [Abstract][Full Text] [Related]
39. Intramuscular immunization with a plasmid DNA vaccine encoding prM-E protein from Japanese encephalitis virus: enhanced immunogenicity by co-administration of GM-CSF gene and genetic fusions of prM-E protein and GM-CSF.
Zhai YZ; Li XM; Zhou Y; Ma L; Feng GH
Intervirology; 2009; 52(3):152-63. PubMed ID: 19521104
[TBL] [Abstract][Full Text] [Related]
40. Microneedle mediated delivery of nanoparticles into human skin.
Coulman SA; Anstey A; Gateley C; Morrissey A; McLoughlin P; Allender C; Birchall JC
Int J Pharm; 2009 Jan; 366(1-2):190-200. PubMed ID: 18812218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
